LivaNova (LIVN) FCF Margin Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1,716.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,811.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,833.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 192.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 261.00 |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | -390.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -390.00 |
| Dec 31, 2025 | -732.00 |
| Sep 30, 2025 | 705.00 |
| Jun 30, 2025 | 376.00 |
| Mar 31, 2025 | 294.00 |
| Dec 31, 2024 | 799.00 |
| Sep 30, 2024 | 703.00 |
| Jun 30, 2024 | 1,782.00 |
| Mar 31, 2024 | -375.00 |
| Dec 31, 2023 | 975.00 |
| Sep 30, 2023 | -843.00 |
| Jun 30, 2023 | -159.00 |
| Mar 31, 2023 | -362.00 |
| Dec 31, 2022 | -611.00 |
| Sep 30, 2022 | 355.00 |
| Jun 30, 2022 | -1,371.00 |
| Mar 31, 2022 | 403.00 |
| Dec 31, 2021 | -169.00 |
| Sep 30, 2021 | 893.00 |
| Jun 30, 2021 | 2,284.00 |
| Mar 31, 2021 | 5,184.00 |
| Dec 31, 2020 | 1,303.00 |
| Sep 30, 2020 | 2,998.00 |
| Jun 30, 2020 | -675.00 |
| Mar 31, 2020 | -4,579.00 |
| Dec 31, 2019 | -445.00 |
| Sep 30, 2019 | -4,517.00 |
| Jun 30, 2019 | -1,630.00 |
| Mar 31, 2019 | -731.00 |
| Dec 31, 2018 | -44.00 |
| Sep 30, 2018 | 128.00 |
| Jun 30, 2018 | 1,100.00 |
| Mar 31, 2018 | -549.00 |
| Dec 31, 2017 | -942.00 |
| Sep 30, 2017 | 287.00 |
| Mar 31, 2017 | 1,065.00 |